History of T-cain: a local anesthetic developed and manufactured in japan.
History of T-cain: a local anesthetic developed and manufactured in japan.
复制标题
T-cain 的历史:一种在日本开发和制造的局部麻醉剂。
DOI:
10.1007/s00540-015-2066-0
复制
发表时间:
2015
影响因子:
2.8
通讯作者:
Masaru Tobe Shigeru Saito
中科院分区:
文献类型:
--
作者:
原 幸治;原西 保典;寺田 忠徳;Masaru Tobe Shigeru Saito
In many anesthesia textbooks written in English, lidocaine, tetracaine, bupivacaine, ropivacaine, and chloroprocaine are listed as useful local anesthetics for spinal anesthesia. In contrast, T-cain is not included in these lists, even though it has been reported to be suitable for spinal anesthesia in Japan. T-cain was developed as a local anesthetic in the early 1940s by Teikoku Kagaku Sangyo Inc. in Itami, Japan, by replacing a methyl group on tetracaine (Pantocaine®) with an ethyl group. T-cain was clinically approved for topical use in Japan in November 1949, and a mixture of dibucaine and T-cain (Neo-Percamin S®) was approved for spinal use in May 1950. Simply because of a lack of foreign marketing strategy, T-cain has never attracted global attention as a local anesthetic. However, in Japan, T-cain has been used topically or intrathecally (as Neo-Percamin S®) for more than 60 years. Other than the side effects generally known for all local anesthetics, serious side effects have not been reported for T-cain. In fact, several articles have reported that T-cain decreases the neurotoxicity of dibucaine. In this historical review, the characteristics of T-cain and its rise to become a major spinal anesthetic in Japan are discussed.